97
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Sustained-release Hydrogels of Ivermectin As Alternative Systems to Improve the Treatment of Cutaneous Leishmaniasis

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 779-790 | Received 28 Jul 2020, Accepted 05 Nov 2020, Published online: 17 Nov 2020
 

Abstract

Background: Leishmaniasis is a neglected tropical disease and its cutaneous form manifests as ulcers or nodules, generally in exposed parts of the body. This work aimed to develop ivermectin (IVM) thermosensitive hydrogels as topical formulations to improve cutaneous leishmaniasis treatment. Materials & methods: Hydrogels based on poloxamers 407 and 188 with different concentrations of IVM were prepared and rheologically characterized. The IVM release profiles were obtained and mathematically analyzed using the Lumped model. Results: The formulation containing 1.5% w/w of IVM presented an adequate gelling temperature, an optimal complex viscosity and elastic modulus. Hydrogels allowed to modulate the release of IVM. Conclusion: IVM thermosensitive hydrogels can be considered a valuable alternative to improve the treatment of cutaneous leishmaniasis.

Financial & competing interests disclosure

Authors would like to thank for financial support the Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT) [grant number PICT 2017-4571], Consejo Nacional de Investigaciones Científicas y Técnicas [grant number 11220170100759CO], and Consejo de Investigación Universidad Nacional de Salta (CIUNSa) [grant numbers 2471, 2522]. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript

Ethical conduct of research

This article does not contain any studies involving human participants performed by any of the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.